[1] 温建燔, 张刚庆, 高训锋,等. 原发性肝癌中FYVE-CENT、Ki-67的表达及意义. 临床和实验医学杂志, 2016, 15: 969-972.
[2] Ivanova OK, Sharapova TN, Romanova EA, et al. CD3+ CD8+ NKG2D+ T Lymphocytes Induce Apoptosis and Necroptosis in HLA-negative Cells via FasL-Fas Interaction. J Cell Biochem, 2017, 118: 3359-3366.
[3] 方锋凯, 王文明, 林喜风. 超声检查在预测不同部位的肝细胞肝癌术后复发率中的诊断价值分析. 中国地方病防治杂志, 2017, 32: 577.
[4] Heegaard S, Sommer HM, Broholm H, et al. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis. Cancer, 1995, 76: 1809-1813.
[5] Wang W, Wu J, Zhang P, et al. Prognostic and predictive value of Ki-67 in triple-negative breast cancer. Oncotarget, 2016, 7: 31079-31087.
[6] Saito K, Mori S, Tanda N, et al. Expression of p53 protein and Ki-67 antigen in gingival hyperplasia induced by nifedipine and phenytoin. J Periodontol, 1999, 70: 581-586.
[7] 胡利霞, 涂雪松, 陈玉环,等. Ki-67抗原与CDK8在宫颈癌及宫颈上皮内瘤变中的表达及临床意义. 癌症进展, 2016, 14: 350-352,356.
[8] Milanovic D, Pesic V, Loncarevic-Vasiljkovic N, et al. The Fas Ligand/Fas Death Receptor Pathways Contribute to Propofol-Induced Apoptosis and Neuroinflammation in the Brain of Neonatal Rats. Neurotox Res, 2016, 30: 434-452.
[9] 胡超华, 丁佑铭. Fas/FasL在肝癌细胞中的表达与肝癌浸润转移关系相关性研究. 中国普外基础与临床杂志, 2015, 22: 99-101.
[10] Guo CL, Yang XH, Cheng W, et al. Expression of Fas/FasL in CD8+ T and CD3+ Foxp3+ Treg cells-relationship with apoptosis of circulating CD8+ T cells in hepatocellular carcinoma patients. Asian Pac J Cancer Prev, 2014, 15: 2613-2618. |
